Position in ABVX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$269,851
New position
Shares Held
2,025
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#227
of 302 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pine Valley Investments Ltd Liability Co holds $6,245,807 across 6 Biotechnology names. ABVX ranks #5 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,783 | $2,982,391 | |
| 2 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
23,248 | $1,894,944 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,381 | $685,984 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
4,049 | $352,060 | |
| 5 | ABVX |
Abivax S.A.
This page
|
2,025 | $269,851 | |
| 6 | RXRX |
Recursion Pharmaceuticals, Inc.
|
16,506 | $60,577 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $269,851 | 2,025 | Shares | Sole | 2026-07-24 | |
| No filing history on record for this holder in this stock. | ||||||